RE:RE:Novozyme, GSK once weekly diabetes treatmentNot official yet...
The first approval for a product based on Novozymes’ VELTIS technology.
This technology extand the half life of albumin.
But you have to extract the albumin first, and that need a specific ligand. This is the part that should involve PLI with GSK.